|
Kilian Kelly PhD
Chief Executive Officer and Managing Director
Cynata Therapeutics
Cremorne, VIC
Australia
|
Dr Kilian Kelly is Chief Executive Officer and Managing Director of the stem cell and regenerative medicine company, Cynata Therapeutics Limited, which is based in Melbourne, Australia. Kilian joined Cynata in 2014, initially as Vice President. Product Development, and subsequently Chief Operating Officer, before taking the role of CEO and MD in July 2023. Prior to Cynata, he held positions at range of small and large companies, including Biota Pharmaceuticals, Mesoblast Limited, Kendle International, Amgen and AstraZeneca. He holds a Masters in Pharmacy from Robert Gordon University, Aberdeen and a PhD in Pharmaceutical Sciences from Strathclyde University, Glasgow. He is a registered pharmacist and a member of the Royal Pharmaceutical Society, the Australian Institute of Company Directors, and the International Society for Cell and Gene Therapy. He also currently serves on the Industry Interface Committee of the Center for Commercialisation of Regenerative Medicine (CCRM) Australia.